Strategies for Prevention and Management of Bleeding Following Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Scoping Review

Pediatric Critical Care Medicine

Volumn 19, Issue 1, 2018, Pages 40-47

  Siemens, Kristina ^a   Sangaran, Dilanee P ^a   Hunt, Beverley J ^a   Murdoch, Ian A ^a   Tibby, Shane M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

bleeding; cardiopulmonary bypass; congenital heart disease; hemorrhage; pediatric

Indexed keywords

ANTIFIBRINOLYTIC AGENT;

BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; CYANOTIC HEART DISEASE; HEART SURGERY; HUMAN; LUNG HEMORRHAGE; PEDIATRIC SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; ADOLESCENT; BLOOD COMPONENT THERAPY; CHILD; HEMOSTASIS; INFANT; MEDIASTINUM; PRESCHOOL CHILD; PROCEDURES; STATISTICS AND NUMERICAL DATA; SURGERY;

ADOLESCENT; BLOOD COMPONENT TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; HEMOSTASIS, SURGICAL; HUMANS; INFANT; MEDIASTINUM; POSTOPERATIVE HEMORRHAGE;

EID: 85040547053     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000001387     Document Type: Conference Paper

References (65)

1. Hoffman JI, Kaplan S: The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890-1900
2. Bernier PL, Stefanescu A, Samoukovic G, et al: The challenge of congenital heart disease worldwide: Epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2010; 13:26-34
3. Pierpont ME, Basson CT, Benson DW Jr, et al; American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Genetic basis for congenital heart defects: Current knowledge: A scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 2007; 115:3015-3038
4. Perloff JK, Warnes CA: Challenges posed by adults with repaired congenital heart disease. Circulation 2001; 103:2637-2643
5. Bédard E, Shore DF, Gatzoulis MA: Adult congenital heart disease: A 2008 overview. Br Med Bull 2008; 85:151-180
6. Moons P, Bovijn L, Budts W, et al: Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 2010; 122:2264-2272
7. Marelli AJ, Mackie AS, Ionescu-Ittu R, et al: Congenital heart disease in the general population: Changing prevalence and age distribution. Circulation 2007; 115:163-172
8. Warnes CA, Williams RG, Bashore TM, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease); American Society of Echocardiography; Heart Rhythm Society; International Society for Adult Congenital Heart Disease; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons: ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:e143-e263
9. Society of Thoracic Surgeons: Executive Summary Congenital Heart Surgery Database-Spring 2016 Harvest, 2016. Available at: http:// www.sts.org/national-database/database-managers/executive-summaries. Accessed December 1, 2016
10. Franklin R, Cunningham D, Whittaker T, et al: National Congenital Heart Disease Audit Report 2012-2015. London, National Institute for Cardiovascular Outcomes Research (NICOR), 2016. Available at: https://nicor5.nicor.org.uk/chd/anpaeds.nsf/vwContent/ home?Opendocument. Accessed December 1, 2016
11. Hoffman JIE: The global burden of congenital heart disease. Cardiovasc J Afr 2013; 24:141-145
12. Neirotti R: Paediatric cardiac surgery in less privileged parts of the world. Cardiol Young 2004; 14:341-346
13. Williams GD, Bratton SL, Ramamoorthy C: Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89:57-64
14. Petäjä J, Lundström U, Leijala M, et al: Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 1995; 109:524-529
15. Wolf MJ, Maher KO, Kanter KR, et al: Early postoperative bleeding is independently associated with increased surgical mortality in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2014; 148:631-636.e1
16. Redlin M, Kukucka M, Boettcher W, et al: Blood transfusion determines postoperative morbidity in pediatric cardiac surgery applying a comprehensive blood-sparing approach. J Thorac Cardiovasc Surg 2013; 146:537-542
17. Agarwal HS, Barrett SS, Barry K, et al: Association of blood products administration during cardiopulmonary bypass and excessive post-operative bleeding in pediatric cardiac surgery. Pediatr Cardiol 2015; 36:459-467
18. Slonim AD, Joseph JG, Turenne WM, et al: Blood transfusions in children: A multi-institutional analysis of practices and complications. Transfusion 2008; 48:73-80
19. Stainsby D, Jones H, Wells AW, et al; SHOT Steering Group: Adverse outcomes of blood transfusion in children: Analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. Br J Haematol 2008; 141:73-79
20. Keung CY, Smith KR, Savoia HF, et al: An audit of transfusion of red blood cell units in pediatric anesthesia. Paediatr Anaesth 2009; 19:320-328
21. New HV, Kelleher A, Arnold P, et al: A multicentre prospective observational survey of the perioperative use of blood components in paediatric cardiac surgery. Br J Haematol 2011; 153(Suppl 1):11
22. Kipps AK, Wypij D, Thiagarajan RR, et al: Blood transfusion is associated with prolonged duration of mechanical ventilation in infants undergoing reparative cardiac surgery. Pediatr Crit Care Med 2011; 12:52-56
23. Engoren MC, Habib RH, Zacharias A, et al: Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74:1180-1186
24. Salvin JW, Scheurer MA, Laussen PC, et al: Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg 2011; 91:204-210
25. Kneyber MC, Hersi MI, Twisk JW, et al: Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med 2007; 33:1414-1422
26. Manno CS, Hedberg KW, Kim HC, et al: Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991; 77:930-936
27. Johansson PI, Sølbeck S, Genet G, et al: Coagulopathy and hemostatic monitoring in cardiac surgery: An update. Scand Cardiovasc J 2012; 46:194-202
28. Arnold P: Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery. Paediatr Anaesth 2011; 21:494-503
29. Williams GD, Bratton SL, Nielsen NJ, et al: Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1998; 12:633-638
30. Shen I, Giacomuzzi C, Ungerleider RM: Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants. Ann Thorac Surg 2003; 75:S729-S734
31. Chan AK, Leaker M, Burrows FA, et al: Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997; 77:270-277
32. Eaton MP, Iannoli EM: Coagulation considerations for infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth 2011; 21:31-42
33. Levy JH, Tanaka KA: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003; 75:S715-S720
34. Paparella D, Brister SJ, Buchanan MR: Coagulation disorders of cardiopulmonary bypass: A review. Intensive Care Med 2004; 30:1873-1881
35. Wilkinson KL, Brunskill SJ, Doree C, et al: Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease. Cochrane Database Syst Rev 2014; 7:CD009752
36. Esmon CT: The interactions between inflammation and coagulation. Br J Haematol 2005; 131:417-430
37. Koster A, Chew D, Kuebler W, et al: High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2003; 126:906-907
38. Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, et al: Protective effects of steroids in cardiac surgery: A meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth 2011; 25:156-165
39. Williams GD, Bratton SL, Riley EC, et al: Association between age and blood loss in children undergoing open heart operations. Ann Thorac Surg 1998; 66:870-875
40. Kuhle S, Male C, Mitchell L: Developmental hemostasis: Pro-and anticoagulant systems during childhood. Semin Thromb Hemost 2003; 29:329-338
41. Miller BE, Mochizuki T, Levy JH, et al: Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997; 85:1196-1202
42. Williams MD, Chalmers EA, Gibson BE; Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology: The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002; 119:295-309
43. Bull C: Key issues in retrospective evaluation of morbidity outcomes following paediatric cardiac surgery, 2000. Available at: http://webarchive. nationalarchives.gov.uk/20090811150351/http:/www.bristolinquiry. org.uk/finalreport/annexb/images/otherpdfs/replacements/ BullmorbidityR.pdf. Accessed December 1, 2016
44. Guay J, Rivard GE: Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 1996; 62:1955-1960
45. Osthaus WA, Boethig D, Johanning K, et al: Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008; 19:220-225
46. Harker LA: Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314:1446-1448
47. Tempe DK, Virmani S: Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 2002; 16:752-765
48. McEwan A: Aspects of bleeding after cardiac surgery in children. Paediatr Anaesth 2007; 17:1126-1133
49. Duffett M, Choong K, Hartling L, et al: Randomized controlled trials in pediatric critical care: A scoping review. Crit Care 2013; 17:R256
50. Caldwell PH, Murphy SB, Butow PN, et al: Clinical trials in children. Lancet 2004; 364:803-811
51. Cohen E, Uleryk E, Jasuja M, et al: An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. J Clin Epidemiol 2007; 60:118-123
52. Moher D, Liberati A, Tetzlaff J, et al; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339:b2535
53. Arksey H, O'Malley L: Scoping studies: Towards a methodological framework. Int J Soc Res Methodol 2005; 8: 19-32
54. Colquhoun HL, Levac D, O'Brien KK, et al: Scoping reviews: Time for clarity in definition, methods, and reporting. J Clin Epidemiol 2014; 67:1291-1294
55. Klassen TP, Hartling L, Hamm M, et al: StaR Child Health: An initiative for RCTs in children. Lancet 2009; 374:1310-1312
56. Williamson PR, Altman DG, Blazeby JM, et al: Developing core outcome sets for clinical trials: Issues to consider. Trials 2012; 13:132
57. Sinha I, Jones L, Smyth RL, et al: A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med 2008; 5:e96
58. Moganasundram S, Hunt BJ, Sykes K, et al: The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children. Anesth Analg 2010; 110:995-1002
59. Schulman SR, Kern FH, Erb TO, et al: Coagulation disorders in congenital heart disease. In: Critical Heart Disease in Infants and Children. Nichols DG UR, Spevak PJ, Greeley WJ, et al (Eds). Philadelphia, Elsevier, 2006, p. 375
60. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al: Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382
61. Timpa JG, O'Meara LC, Goldberg KG, et al: Implementation of a multidisciplinary bleeding and transfusion protocol significantly decreases perioperative blood product utilization and improves some bleeding outcomes. J Extra Corpor Technol 2016; 48:11-18
62. Machovec KA, Smigla G, Ames WA, et al: Reduction in blood transfusion in a cohort of infants having cardiac surgery with cardiopulmonary bypass after instituting a goal-directed transfusion policy. Perfusion 2016; 31:598-603
63. Cui Y, Hei F, Long C, et al: Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. Artif Organs 2010; 34:955-960
64. Codispoti M, Ludlam CA, Simpson D, et al: Individualized heparin and protamine management in infants and children undergoing cardiac operations. Ann Thorac Surg 2001; 71:922-927
65. Guzzetta NA, Bajaj T, Fazlollah T, et al: A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Anesth Analg 2008; 106:419-425, table of contents